{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:38:34Z","timestamp":1772782714418,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014809","name":"Technology Agency of the Czech Republic","doi-asserted-by":"publisher","award":["TO01000078"],"award-info":[{"award-number":["TO01000078"]}],"id":[{"id":"10.13039\/100014809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018512","name":"Univerzita Hradec Kr\u00e1lov\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["CZ.02.01.01\/00\/22_008\/0004562"],"award-info":[{"award-number":["CZ.02.01.01\/00\/22_008\/0004562"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejmech.2024.116130","type":"journal-article","created":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T00:52:57Z","timestamp":1704588777000},"page":"116130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition"],"prefix":"10.1016","volume":"266","author":[{"given":"Anna","family":"Misiachna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbora","family":"Svobodova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Netolicky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marketa","family":"Chvojkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka","family":"Kleteckova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Prchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Novak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Hrabinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Kucera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubica","family":"Muckova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Moravcova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana Zdarova","family":"Karasova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslav","family":"Pejchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Blazek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Malinak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Hakenova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbora Hrcka","family":"Krausova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marharyta","family":"Kolcheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Ladislav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Korabecny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Pahnke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Vales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Horak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6376-8701","authenticated-orcid":false,"given":"Ondrej","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116130_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.1992.tb04458.x","article-title":"Putative mechanisms of action of tacrine in alzheimers-disease","volume":"85","author":"Adem","year":"1992","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ejmech.2024.116130_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/1567205011310080011","article-title":"A resurrection of 7-MEOTA: a comparison with tacrine","volume":"10","author":"Soukup","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2024.116130_bib3","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","article-title":"Hepatotoxic effects of tacrine administration in patients with alzheimers-disease","volume":"271","author":"Watkins","year":"1994","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.ejmech.2024.116130_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2165\/00023210-199504030-00002","article-title":"Tacrine-induced hepatotoxicity","volume":"4","author":"Balson","year":"1995","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2024.116130_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2016.10.060","article-title":"A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease","volume":"128","author":"Sameem","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116130_bib6","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2174\/1568026605666160927152728","article-title":"Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer's disease","volume":"17","author":"Spilovska","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116130_bib7","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.3390\/ijms21175965","article-title":"Merged tacrine-based, multitarget-directed acetylcholinesterase inhibitors 2015\u2013present: synthesis and biological activity","volume":"21","author":"Eckroat","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116130_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11696-018-0590-8","article-title":"Tacrine hybrids as multi-target-directed ligands in Alzheimer's disease: influence of chemical structures on biological activities","volume":"73","author":"Girek","year":"2019","journal-title":"Chem. Pap."},{"key":"10.1016\/j.ejmech.2024.116130_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tips.2020.04.008","article-title":"A perspective on multi-target drugs for alzheimer's disease","volume":"41","author":"Benek","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2024.116130_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2017.01.003","article-title":"The pharmacology of tacrine at N-methyl-d-aspartate receptors","volume":"75","author":"Horak","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejmech.2024.116130_bib11","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1016\/j.csbj.2021.07.041","article-title":"Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - design, synthesis and biological evaluation","volume":"19","author":"Remya","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2024.116130_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuropharm.2018.08.010","article-title":"7-Methoxyderivative of tacrine is a \u2018foot-in-the-door\u2019open-channel blocker of GluN1\/GluN2 and GluN1\/GluN3 NMDA receptors with neuroprotective activity in vivo","volume":"140","author":"Kaniakova","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2024.116130_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7252882","article-title":"Tacrine derivatives in neurological disorders: focus on molecular mechanisms and neurotherapeutic potential","volume":"2022","author":"Mitra","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2024.116130_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-11-31","article-title":"Neuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage","volume":"11","author":"Fang","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejmech.2024.116130_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neulet.2008.05.007","article-title":"Bis(7)-tacrine, a promising anti-Alzheimer's dimer, affords dose- and time-dependent neuroprotection against transient focal cerebral ischemia","volume":"439","author":"Zhao","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2024.116130_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114460","article-title":"7-phenoxytacrine is a dually acting drug with neuroprotective efficacy in vivo","volume":"186","author":"Kaniakova","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116130_bib17","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1021\/acschembio.3c00219","article-title":"Tacrine first-phase biotransformation and associated hepatotoxicity: a possible way to avoid quinone methide formation","volume":"18","author":"Novak","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116130_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115154","article-title":"UHPLC-Orbitrap study of the first phase tacrine in vitro metabolites and related Alzheimer's drug candidates using human liver microsomes","volume":"224","author":"Novak","year":"2023","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2024.116130_bib19","first-page":"874","article-title":"Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference","volume":"21","author":"Woolf","year":"1993","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2024.116130_bib20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/1567205011310080011","article-title":"A resurrection of 7-MEOTA: a comparison with tacrine","volume":"10","author":"Soukup","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2024.116130_bib21","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2174\/1871527320666210309141627","article-title":"GluN2B\/N-methyl-D-aspartate receptor antagonists: advances in design, synthesis, and pharmacological evaluation studies, CNS neurol. Disord","volume":"20","author":"Ugale","year":"2021","journal-title":"Drug Targets"},{"key":"10.1016\/j.ejmech.2024.116130_bib22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/exnr.2000.7444","article-title":"Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease","volume":"165","author":"Nash","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2024.116130_bib23","first-page":"1211","article-title":"Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia","volume":"247","author":"Gotti","year":"1988","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116130_bib24","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1523\/JNEUROSCI.0226-17.2017","article-title":"A GluN2B-selective NMDAR antagonist reverses synapse loss and cognitive impairment produced by the HIV-1 protein tat","volume":"37","author":"Raybuck","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116130_bib25","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.neuropharm.2012.07.012","article-title":"Ifenprodil, a NR2B-selective antagonist of NMDA receptor, inhibits reverse Na+\/Ca2+ exchanger in neurons","volume":"63","author":"Brittain","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2024.116130_bib26","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1021\/jo9012157","article-title":"(2-Pyridyl)acetone-Promoted Cu-Catalyzed O-arylation of phenols with aryl iodides, bromides, and chlorides","volume":"74","author":"Zhang","year":"2009","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.116130_bib27","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/acs.jmedchem.7b01664","article-title":"Design and synthesis of novel deuterated ligands functionally selective for the \u03b3-aminobutyric acid type A receptor (GABA(A)R) \u03b16 subtype with improved metabolic stability and enhanced bioavailability","volume":"61","author":"Knutson","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116130_bib28","first-page":"1350","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2024.116130_bib29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1124\/mol.115.103036","article-title":"A novel binding mode reveals two distinct classes of NMDA receptor GluN2B-selective antagonists","volume":"89","author":"Stroebel","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116130_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hipo.20367","article-title":"A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats","volume":"18","author":"Manahan\u2010Vaughan","year":"2008","journal-title":"Hippocampus"},{"key":"10.1016\/j.ejmech.2024.116130_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0091-3057(94)90506-1","article-title":"Glutamate antagonists have different effects on spontaneous locomotor activity in rats","volume":"48","author":"Danysz","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2024.116130_bib32","series-title":"Injury Models of the Central Nervous System: Methods and Protocols","first-page":"553","article-title":"Assessment of cognitive function in the water maze task: maximizing data collection and analysis in animal models of brain injury","author":"Whiting","year":"2016"},{"key":"10.1016\/j.ejmech.2024.116130_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0014-2999(99)00643-3","article-title":"Effect of rivastigmine on scopolamine-induced memory impairment in rats","volume":"383","author":"Bejar","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116130_bib34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00213-016-4488-2","article-title":"Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans","volume":"234","author":"Lacz\u00f3","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2024.116130_bib35","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.lfs.2004.06.028","article-title":"The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats","volume":"76","author":"Janas","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2024.116130_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(93)90106-U","article-title":"MK-801 increases endogenous acetylcholine release in the rat parietal cortex: a study using brain microdialysis","volume":"150","author":"Hasegawa","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2024.116130_bib37","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuropharm.2011.06.008","article-title":"Effects of memantine and donepezil on cortical and hippocampal acetylcholine levels and object recognition memory in rats","volume":"61","author":"Ihalainen","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2024.116130_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1254\/jphs.12166SC","article-title":"Synergistic effects of galantamine and memantine in attenuating scopolamine-induced amnesia in mice","volume":"120","author":"Busquet","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2024.116130_bib39","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.neuropharm.2016.02.035","article-title":"Rat intra-hippocampal NMDA infusion induces cell-specific damage and changes in expression of NMDA and GABAA receptor subunits","volume":"105","author":"Rambousek","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2024.116130_bib40","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1016\/j.csbj.2021.07.041","article-title":"Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase \u2013 design, synthesis and biological evaluation","volume":"19","author":"Remya","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2024.116130_bib41","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.pbb.2007.03.006","article-title":"Evaluation of acute bis(7)-tacrine treatment on behavioral functions in 17-day-old and 30-day-old mice, with attention to drug toxicity","volume":"86","author":"Pan","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2024.116130_bib42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1124\/mol.115.103036","article-title":"A novel binding mode reveals two distinct classes of NMDA receptor GluN2B-selective antagonists","volume":"89","author":"Stroebel","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116130_bib43","first-page":"22","article-title":"Novel tacrine-scutellarin hybrids as multipotent anti-alzheimer's agents: design, synthesis and biological evaluation","author":"Spilovska","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116130_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2016.05.058","article-title":"Towards understanding the mechanism of action of antibacterial N-alkyl-3-Hydroxypyridinium salts: biological activities, molecular modeling and QSAR studies","author":"Dolezal","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116130_bib45","series-title":"Guidance on Dose Level Selection on for Regul\u00e1tory General Toxikology Studies for Pharmaceuticals","author":"Robinson","year":"2009"},{"key":"10.1016\/j.ejmech.2024.116130_bib46","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2174\/1567205015666171212105412","article-title":"Cholinesterase inhibitor 6-chlorotacrine - in vivo toxicological profile and behavioural effects","volume":"15","author":"Misik","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2024.116130_bib47","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1021\/acschemneuro.1c00184","article-title":"Phenothiazine-tacrine heterodimers: pursuing multitarget directed approach in alzheimer's disease","volume":"12","author":"Gorecki","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116130_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2014.01.057","article-title":"Neuroprotective effect of the 3alpha5beta-pregnanolone glutamate treatment in the model of focal cerebral ischemia in immature rats","volume":"564","author":"Kleteckova","year":"2014","journal-title":"Neurosci. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T02:15:41Z","timestamp":1722910541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424000102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":48,"alternative-id":["S0223523424000102"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116130","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116130"}}